Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting
2023 ESMO WCGIC Insights: "Phase 3 LEAP-017 Study - Lenvatinib + Pembrolizumab vs. Standard of Care for Previously Treated mCRC"
Comments 0
Login to view comments.
Click here to Login
